Adult Congenital Heart Disease — Written Clinical Reasoning · Phys Written Answers

Prompt

DCE-style written reasoning for Adult Congenital Heart Disease.

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Adult Congenital Heart Disease and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Wolf SEM, Jiang H, Boyd RR, Overman RE Jr, et al. Age-Stratified Presentation and Outcomes Following Repair of Anomalous Left Coronary Artery From the Pulmonary Artery World J Pediatr Congenit Heart Surg, 2026.PMID 42454881
[2]Habibi H, Brida M, Gatzoulis MA Beyond survival: empowering adults with congenital heart disease through communication and co-designed education J Thorac Dis, 2026.PMID 42444962
[3]Veldtman H, Nizam MA, Brock S, Kandi S, et al. A bibliometric analysis of medication studies in congenital heart disease Int J Cardiol Congenit Heart Dis, 2026.PMID 42438601
[4]Batra AS, Hamidy M, McCanta A, Sell L, et al. Practice Variation in Infective Endocarditis Prophylaxis for Pediatric and Congenital Heart Disease Patients with Cardiac Implantable Electronic Devices: An International Survey Pediatr Cardiol, 2026.PMID 42423984
[5]Das BB Advances and unmet needs in pharmacologic therapy for pediatric heart failure: Insights from the 2025 International Society for Heart and Lung Transplantation Guidelines Ann Pediatr Cardiol, 2026.PMID 42404509
[6]Kholeif Z, Ellabbad M, Miranda WR, Connolly HM, et al. Clinical benefit of optimization of heart failure therapy after heart failure hospitalization in adults with CHD Int J Cardiol Congenit Heart Dis, 2026.PMID 42376565
[7]Doan HN, Chang MC Comparative Effectiveness of Unstable Versus Stable Resistance Training on Lower Limb Strength, Mobility, and Fear of Falling in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials Am J Phys Med Rehabil, 2026.PMID 42468010
[8]Liu HW, Tsai TL Virtual Reality-assisted Physiotherapeutic Training for Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis Am J Phys Med Rehabil, 2026.PMID 42468005

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Adult Congenital Heart Disease and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Wolf SEM, Jiang H, Boyd RR, Overman RE Jr, et al. Age-Stratified Presentation and Outcomes Following Repair of Anomalous Left Coronary Artery From the Pulmonary Artery World J Pediatr Congenit Heart Surg, 2026.PMID 42454881
[2]Habibi H, Brida M, Gatzoulis MA Beyond survival: empowering adults with congenital heart disease through communication and co-designed education J Thorac Dis, 2026.PMID 42444962
[3]Veldtman H, Nizam MA, Brock S, Kandi S, et al. A bibliometric analysis of medication studies in congenital heart disease Int J Cardiol Congenit Heart Dis, 2026.PMID 42438601
[4]Batra AS, Hamidy M, McCanta A, Sell L, et al. Practice Variation in Infective Endocarditis Prophylaxis for Pediatric and Congenital Heart Disease Patients with Cardiac Implantable Electronic Devices: An International Survey Pediatr Cardiol, 2026.PMID 42423984
[5]Das BB Advances and unmet needs in pharmacologic therapy for pediatric heart failure: Insights from the 2025 International Society for Heart and Lung Transplantation Guidelines Ann Pediatr Cardiol, 2026.PMID 42404509
[6]Kholeif Z, Ellabbad M, Miranda WR, Connolly HM, et al. Clinical benefit of optimization of heart failure therapy after heart failure hospitalization in adults with CHD Int J Cardiol Congenit Heart Dis, 2026.PMID 42376565
[7]Doan HN, Chang MC Comparative Effectiveness of Unstable Versus Stable Resistance Training on Lower Limb Strength, Mobility, and Fear of Falling in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials Am J Phys Med Rehabil, 2026.PMID 42468010
[8]Liu HW, Tsai TL Virtual Reality-assisted Physiotherapeutic Training for Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis Am J Phys Med Rehabil, 2026.PMID 42468005